Literature DB >> 8749132

High-resolution MRI of the human cochlea.

I Koizuka1, R Seo, T Kubo, T Matsunaga, M Murakami, Y Seo, H Watari.   

Abstract

The majority of magnetic resonance imaging (MRI) studies in neurotology concern the evaluation of retrocochlear pathologies or temporal bone lesions. Recently, quite a number of investigators have attempted to use imaging diagnosis to obtain a diagnosis and manifest the pathological findings of Meniere's disease. However, there is no evidence that endolymphatic hydrops in patients with Meniere's disease can be identified by imaging techniques. In this study we could depict Reissner's membrane clearer than before with the use of image processing. At the present time, we cannot apply the 2.11T MRI machine to patients under FDA regulation. We believe that MRI diagnoses of endolymphatic hydrops and small lesions of the internal structures of the inner ear will be possible in the near future.

Entities:  

Mesh:

Year:  1995        PMID: 8749132     DOI: 10.3109/00016489509125241

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  3 in total

1.  Imaging of endolymphatic and perilymphatic fluid at 3T after intratympanic administration of gadolinium-diethylene-triamine pentaacetic acid.

Authors:  S Naganawa; M Sugiura; M Kawamura; H Fukatsu; M Sone; T Nakashima
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

2.  MRI performed after intratympanic gadolinium administration in patients with Ménière's disease: correlation with symptoms and signs.

Authors:  Francesco Fiorino; Francesca B Pizzini; Alberto Beltramello; Franco Barbieri
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-10       Impact factor: 2.503

3.  Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla.

Authors:  Shinji Naganawa; Hiroko Satake; Minako Kawamura; Hiroshi Fukatsu; Michihiko Sone; Tsutomu Nakashima
Journal:  Eur Radiol       Date:  2008-03-07       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.